MSFrontier

Corrections log

When a reader or our own checks find an error, we fix the rule or record the correction in the open. Every correction below is applied automatically at each weekly update.

2 November 2026

OCTOPUS (PLATYPUS in Australia)

  • Medicines: metformin, thioctic acid
  • Approach: Mitochondrial / oxidative stress
  • Area: Nerve and brain biology
  • Curation note: Interim stage-1 analysis (Sep 2026): alpha-lipoic acid continues to stage 2; metformin arm discontinued

Registry redacts arm drugs. First two arms named publicly as metformin and R/S alpha-lipoic acid.

Mechanism node assigned from the named arm drugs.

Interim result. Not a final efficacy result.

Source ↗Source ↗

Spotted an error?

Tell us through the contact form. We fix the rule, so the fix applies everywhere the record appears.

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error